492 related articles for article (PubMed ID: 24884959)
1. Studies of cardiovascular risk factors in polycystic ovary syndrome patients combined with subclinical hypothyroidism.
Pei YJ; Wang AM; Zhao Y; Yan L; Li M; White RE; Han GC
Gynecol Endocrinol; 2014 Aug; 30(8):553-6. PubMed ID: 24884959
[TBL] [Abstract][Full Text] [Related]
2. Is subclinical hypothyroidism contributing dyslipidemia and insulin resistance in women with polycystic ovary syndrome?
Celik C; Abali R; Tasdemir N; Guzel S; Yuksel A; Aksu E; Yılmaz M
Gynecol Endocrinol; 2012 Aug; 28(8):615-8. PubMed ID: 22329744
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk markers and thyroid status in young Indian women with polycystic ovarian syndrome: a case-control study.
Sravan Kumar P; Ananthanarayanan PH; Rajendiran S
J Obstet Gynaecol Res; 2014 May; 40(5):1361-7. PubMed ID: 24750325
[TBL] [Abstract][Full Text] [Related]
4. Subclinical hypothyroidism in patients with polycystic ovary syndrome: distribution and its association with lipid profiles.
Huang R; Zheng J; Li S; Tao T; Liu W
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():52-6. PubMed ID: 24768234
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
[TBL] [Abstract][Full Text] [Related]
6. Association of subclinical hypothyroidism and phenotype, insulin resistance, and lipid parameters in young women with polycystic ovary syndrome.
Ganie MA; Laway BA; Wani TA; Zargar MA; Nisar S; Ahamed F; Khurana ML; Ahmed S
Fertil Steril; 2011 May; 95(6):2039-43. PubMed ID: 21333983
[TBL] [Abstract][Full Text] [Related]
7. Association of Subclinical Hypothyroidism with Dyslipidemia and Increased Carotid Intima-Media Thickness in Children.
Unal E; Akın A; Yıldırım R; Demir V; Yildiz İ; Haspolat YK
J Clin Res Pediatr Endocrinol; 2017 Jun; 9(2):144-149. PubMed ID: 28008862
[TBL] [Abstract][Full Text] [Related]
8. Subclinical hypothyroidism in young women with polycystic ovary syndrome: an analysis of clinical, hormonal, and metabolic parameters.
Benetti-Pinto CL; Berini Piccolo VR; Garmes HM; Teatin Juliato CR
Fertil Steril; 2013 Feb; 99(2):588-92. PubMed ID: 23103018
[TBL] [Abstract][Full Text] [Related]
9. Clinical, Hormonal, and Metabolic Parameters in Women with Subclinical Hypothyroidism and Polycystic Ovary Syndrome: A Cross-Sectional Study.
Bedaiwy MA; Abdel-Rahman MY; Tan J; AbdelHafez FF; Abdelkareem AO; Henry D; Lisonkova S; Hurd WW; Liu JH
J Womens Health (Larchmt); 2018 May; 27(5):659-664. PubMed ID: 29620956
[TBL] [Abstract][Full Text] [Related]
10. Is serum leptin level regulated by thyroid functions, lipid metabolism and insulin resistance in polycystic ovary syndrome?
Erel CT; Senturk LM; Kaleli S; Gezer A; Baysal B; Tasan E
Gynecol Endocrinol; 2003 Jun; 17(3):223-9. PubMed ID: 12857430
[TBL] [Abstract][Full Text] [Related]
11. Impact of elevated thyroid-stimulating hormone levels in polycystic ovary syndrome.
Trummer C; Schwetz V; Giuliani A; Obermayer-Pietsch B; Lerchbaum E
Gynecol Endocrinol; 2015 Oct; 31(10):819-23. PubMed ID: 26190535
[TBL] [Abstract][Full Text] [Related]
12. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
Verit FF
Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
[TBL] [Abstract][Full Text] [Related]
13. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
Wan DH; Fan P; Bai H; Song Q; Liu HW
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
[TBL] [Abstract][Full Text] [Related]
14. Decreased deiodinase activity after glucose load could lead to atherosclerosis in euthyroid women with polycystic ovary syndrome.
Adamska A; Krentowska A; Łebkowska A; Hryniewicka J; Leśniewska M; Adamski M; Kowalska I
Endocrine; 2019 Jul; 65(1):184-191. PubMed ID: 30945110
[TBL] [Abstract][Full Text] [Related]
15. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
16. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
Meyer C; McGrath BP; Teede HJ
J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
[TBL] [Abstract][Full Text] [Related]
17. Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers.
Patel SS; Truong U; King M; Ferland A; Moreau KL; Dorosz J; Hokanson JE; Wang H; Kinney GL; Maahs DM; Eckel RH; Nadeau KJ; Cree-Green M
Vasc Med; 2017 Apr; 22(2):85-95. PubMed ID: 28095749
[TBL] [Abstract][Full Text] [Related]
18. Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome.
Karbek B; Ozbek M; Karakose M; Topaloglu O; Bozkurt NC; Cakır E; Aslan MS; Delibasi T
J Ovarian Res; 2014 Mar; 7():31. PubMed ID: 24628831
[TBL] [Abstract][Full Text] [Related]
19. Thrombin-activatable fibrinolysis inhibitor and cardiovascular risk factors in polycystic ovary syndrome.
Erdoğan M; Karadeniz M; Alper GE; Tamsel S; Uluer H; Cağlayan O; Saygili F; Yilmaz C
Exp Clin Endocrinol Diabetes; 2008 Mar; 116(3):143-7. PubMed ID: 18350479
[TBL] [Abstract][Full Text] [Related]
20. The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study.
Orio F; Palomba S; Spinelli L; Cascella T; Tauchmanovà L; Zullo F; Lombardi G; Colao A
J Clin Endocrinol Metab; 2004 Aug; 89(8):3696-701. PubMed ID: 15292291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
